STOCK TITAN

PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
PTC Therapeutics, Inc. (PTCT) will host a webcast conference call to report Q1 2024 financial results and provide business updates on April 25. Participants can access the call online or by phone, with a replay available on the company's website for 30 days.
Positive
  • None.
Negative
  • None.

SOUTH PLAINFIELD, N.J., April 11, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its first quarter 2024 financial results and provide an update on the company's business and outlook on Thursday, April 25, at 4:30 p.m. ET.  

To access the call by phone, please click here to register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in to the conference call 15 minutes prior to the start of the call. The webcast conference call can be accessed on the Investor section of the PTC website at https://ir.ptcbio.com/events-presentations. A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days.  

About PTC Therapeutics, Inc.  
PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. PTC's mission is to provide access to best-in-class treatments for patients who have little to no treatment options. PTC's strategy is to leverage its strong scientific and clinical expertise and global commercial infrastructure to bring therapies to patients. PTC believes this allows it to maximize value for all its stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, Instagram, LinkedIn and Twitter at @PTCBio.

For More Information:  

Investors:  
Kylie O'Keefe  
+1 (908) 300-0691  
kokeefe@ptcbio.com  

Media:  
Jeanine Clemente  
+1 (908) 912-9406  
jclemente@ptcbio.com  

Cision View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss--first-quarter-2024-financial-results-302113745.html

SOURCE PTC Therapeutics, Inc.

FAQ

When will PTC Therapeutics, Inc. host the webcast conference call to report Q1 2024 financial results?

PTC Therapeutics, Inc. (PTCT) will host the webcast conference call on Thursday, April 25, at 4:30 p.m. ET.

How can participants access the conference call by phone?

Participants can access the conference call by phone after registering via the provided link and receiving dial-in details.

Where can the webcast conference call be accessed online?

The webcast conference call can be accessed on the Investor section of the PTC website at https://ir.ptcbio.com/events-presentations.

Will there be a replay of the conference call available?

Yes, a replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days.

PTC Therapeutics, Inc.

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Stock Data

2.62B
56.48M
2.79%
112.93%
13.39%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
SOUTH PLAINFIELD

About PTCT

ptc is biopharmaceutical company focused on the discovery and development of orally-administered, proprietary small molecule drugs that target post-transcriptional control processes. while ptc’s discovery programs are directed at targets in multiple therapeutic areas, ptc is focusing particularly on the development and commercialization of treatments for orphan and ultra-orphan disorders. post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. ptc’s internally-discovered pipeline addresses multiple therapeutic areas, including neuromuscular disorders, oncology and infectious diseases. for more information on the company, please visit our website www.ptcbio.com.